GAM Systematic’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.37M Buy
18,245
+2,655
+17% +$352K 0.34% 72
2017
Q2
$2.06M Buy
15,590
+1,073
+7% +$137K 0.3% 100
2017
Q1
$1.81M Sell
14,517
-5,328
-27% -$636K 0.36% 65
2016
Q4
$2.29M Sell
19,845
-5,269
-21% -$609K 0.54% 10
2016
Q3
$2.97M Buy
25,114
+5,637
+29% +$684K 0.62% 7
2016
Q2
$2.36M Buy
19,477
+1,119
+6% +$127K 0.57% 5
2016
Q1
$1.99M Sell
18,358
-1,638
-8% -$170K 0.52% 7
2015
Q4
$2.05M Sell
19,996
-7,990
-29% -$804K 0.59% 5
2015
Q3
$2.61M Sell
27,986
-63,001
-69% -$6.09M 0.61% 1
2015
Q2
$8.87M Buy
90,987
+25,117
+38% +$2.52M 1.12% 2
2015
Q1
$6.63M Buy
65,870
+22,504
+52% +$2.29M 0.91% 5
2014
Q4
$4.54M Buy
+43,366
New +$4.57M 0.92% 4

Other funds holding JNJ

GAM Systematic's JNJ Position: Q3 2017 in Review

GAM Systematic increased its Johnson & Johnson (JNJ) stake by 17% in Q3 2017, buying an estimated $352K and bringing the position to 18,245 shares worth $2.37M. The position accounts for 0.34% of the portfolio, ranked #72.

GAM Systematic first reported a position in JNJ in Q4 2014 and has held it in 12 quarters since. The position peaked at $8.87M in Q2 2015. 2,356 funds tracked by Wall St. Rank hold JNJ as of Q3 2017.

  • GAM Systematic held 18,245 shares of Johnson & Johnson worth $2.37M as of Q3 2017.
  • GAM Systematic bought 2,655 Johnson & Johnson shares in Q3 2017, an estimated $352K.
  • Johnson & Johnson made up 0.34% of GAM Systematic's portfolio in Q3 2017, its #72 holding.
  • GAM Systematic first reported a position in Johnson & Johnson in Q4 2014 and has held it in 12 quarters since.
  • GAM Systematic's Johnson & Johnson position peaked at $8.87M in Q2 2015.
  • 2,356 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2017.

Based on GAM Systematic's 13F filing for Q3 2017, filed 14 Nov 2017.